| intends to provide a “should” opinion, please explain the facts or circumstances resulting in this uncertainty, the degree of uncertainty, and add appropriate risk factor disclosure addressing the risk to investors regarding uncertain tax treatment. For guidance, see Section III.C.4 of Staff Legal Bulletin No. 19. Finally, please revise to remove inferences that investors may not rely on such disclosure such as the statement on page 259 that the disclosure is for informational purposes only. |
We respectfully advise the Staff that, in response to the Staff’s comment, we have revised our disclosure in the Amended Form S-4 on pages 38, 223, 263 and 264.
Comment Letter dated April 27, 2021
1. | We note that the Form 6-K filed on April 15, 2021 includes as exhibits a Notice of Meeting, Management Proxy Circular and Form of Proxy. Please advise whether the registrant disseminated proxy cards to shareholders. If so, please advise how doing so is consistent with Securities Act section 5. In responding to this comment, please refer to Securities Act Forms Compliance and Disclosure Interpretation 125.07. |
We acknowledge the Staff’s comment and respectfully advise that the Management Proxy Circular was disseminated to BCAC shareholders in accordance with requirements of Canadian regulations. As a foreign private issuer in the Commission’s Multijurisdictional Disclosure System, BCAC is not subject to the U.S. proxy rules, including requirements to prepare a proxy statement in accordance with Schedule 14A. Instead, the Management Proxy Circular, including the proxy card, is prepared in accordance with and governed by local Canadian regulations. The dissemination of the Management Proxy Circular included the proxy cards relating to the vote on the extension of the permitted timeline for BCAC to complete a qualifying acquisition, the domestication of BCAC into Nevada and the approval of the business combination between VWE and BCAC. However, we believe that, even if the Staff were to view such materials to be so similar to the prospectus filed as part of the Form S-4 as to be a prospectus for purposes of Section 10 of the Securities Act, such materials would not be a proxy statement/prospectus of the type contemplated by Securities Act Forms Compliance and Disclosure Interpretation 125.07 (“C&DI 125.07”).
We also note that the Form S-4 that BCAC has filed with the Commission registers shares of New VWE Holdco to be issued to (1) VWE equity holders as consideration in the merger transaction contemplated by BCAC’s business combination with VWE and (2) BCAC shareholders in connection with BCAC’s domestication into Nevada. It does not register any shares to be issued to BCAC shareholders as consideration in the merger transaction contemplated by the business combination. In fact, BCAC shareholders will not be receiving any shares of New VWE Holdco, or other consideration, in the merger transaction. Instead, BCAC shareholders will simply be continuing their existing investment in a British Colombia corporation domesticating into a Nevada corporation.
It appears that the Staff published C&DI 125.07 out of concern that shareholders, when being asked to vote on a business combination in which such shareholders would receive securities offered as merger consideration if so approved, should have sufficient information regarding the offeror and such securities in advance of submitting a proxy. In respect of our view that C&DI 125.07 is primarily focused on shareholders who are to receive securities as merger consideration, we note that C&DI 125.07 affirms that written communications must be filed on the date of first use - reflecting the requirements of Rule 14a-12 under the Exchange Act, which is not applicable here, and Rules 165 and 425 under the Securities Act, which are applicable here only in respect of the shares to be issued in the merger transaction to VWE equity holders. We also note the language in C&DI 125.07 providing that a “vote on the transaction would amount to an investment decision with respect to the securities being registered[.]” We interpret the reference to “the securities being registered” to relate to the securities to be offered as merger consideration, which in this case would be the shares of New VWE Holdco to be offered to VWE equity holders in the merger transaction. We do not believe that the domestication, in which New VWE Holdco following the domestication will be deemed to be the same entity as BCAC prior to the domestication and all rights, privileges and powers of BCAC will remain vested in New VWE Holdco, raises the types of concerns that led the Staff to publish C&DI 125.07.
Finally, we respectfully note for the Staff that neither BCAC nor VWE has disseminated or will disseminate the form of written consent relating to the consent solicitation described in the Form S-4 to VWE equity holders until the Form S-4 is declared effective by the Commission.
* * * * * * * * *